Author details

Full Name

Josef Pichler

Affiliation

Kepler University Hospital

ORCID

Career Start Year

2006

Papers

H Index

Expertise

CM4AI Collaborator

Nathan Sheffield (CM4AI)

PMID	Paper Title	Journal Title	Published Year
34342680	Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature.	J Neurol	2022
36470898	Federated learning enables big data for rare cancer boundary detection.	Nat Commun	2022
35998208	Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns.	Clin Cancer Res	2022
35303173	Frequency and characteristics of bacterial and viral low-grade infections of the intervertebral discs: a prospective, observational study.	J Orthop Traumatol	2022
35326730	MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy.	Cancers (Basel)	2022
34672349	Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).	Neuro Oncol	2022
30284233	Re-irradiation of recurrent glioblastoma as part of a sequential multimodality treatment concept.	Clin Transl Oncol	2019
30994047	Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.	Acta Oncol	2019
30266892	A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma.	Oncologist	2019
30301187	Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.	Cancers (Basel)	2018
30150718	The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.	Nat Med	2018
30010853	TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma.	Neuro Oncol	2018
25256708	Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.	Neuropathol Appl Neurobiol	2015
25681309	Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis.	Neuro Oncol	2015
25655102	MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.	Clin Cancer Res	2015
24253501	Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry.	Br J Cancer	2014
25338498	A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma.	Clin Cancer Res	2014
24947255	Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?	Future Oncol	2014
24321210	Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy.	Int J Clin Pharmacol Ther	2014
23076770	Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases.	Clin Exp Metastasis	2013
23393205	Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age.	Neuro Oncol	2013
23399039	MRI assessment of relapsed glioblastoma during treatment with bevacizumab: volumetric measurement of enhanced and FLAIR lesions for evaluation of response and progression--a pilot study.	Eur J Radiol	2013
23223340	Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO).	Neuro Oncol	2013
23324355	Clinical neuropathology practice guide 1-2013: molecular subtyping of glioblastoma: ready for clinical use?	Clin Neuropathol	2013
22012135	Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases.	Acta Neuropathol	2012
21181283	[Drug therapy of patients with recurrent glioblastoma: is there any evidence?].	Wien Med Wochenschr	2011
21495907	Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials.	Acta Oncol	2011
20396883	Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance?	Eur J Nucl Med Mol Imaging	2010
20150365	O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients.	Neuro Oncol	2010
19564959	Off-label use of prescription drugs in childhood and adolescence: an analysis of prescription patterns in Germany.	Dtsch Arztebl Int	2009
18362893	FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities.	Oncogene	2008
17342095	Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma.	Br J Cancer	2007
17638524	Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies.	Oligonucleotides	2007
17627256	Somatostatin-receptor positive brain stem glioma visualized by octreoscan.	Neuro Endocrinol Lett	2007
17520189	[Intracerebrally localized sarcoma NOS--an interdisciplinary challenge].	Strahlenther Onkol	2007
16794761	Temozolomide for recurrent or progressive high-grade malignant glioma: results of an Austrian multicenter observational study.	Wien Klin Wochenschr	2006

1 - 36 of 36

Malaka Ameratunga

Australia Central Clinical School, Monash University

Career Start Year 2014

Number of shared co-authors 0

Priya Kumthekar

Northwestern University, Feinberg School of Medicine

Career Start Year 2013

Number of shared co-authors 8

Nicholas Butowski

University of California san francisco

Career Start Year 2005

Number of shared co-authors 13

Joost J C Verhoeff

University Medical Center Utrecht

Career Start Year 2005

Number of shared co-authors 0

Adam M Sonabend

Northwestern University

Career Start Year 2005

Number of shared co-authors 4

Sherise D Ferguson

The University of Texas MD Anderson Cancer Center

Career Start Year 2005

Number of shared co-authors 1

Thomas J Kaley

Memorial Sloan Kettering Cancer Center

Career Start Year 2003

Number of shared co-authors 10

Gelareh Zadeh

University of Toronto

Career Start Year 2003

Number of shared co-authors 19

Marco Skardelly

University Hospital Tubingen, Eberhard-Karls-University Tubingen

Career Start Year 2002

Number of shared co-authors 6

Martin Glas

University Hospital Essen

Career Start Year 2002

Number of shared co-authors 11

Andrew P Morokoff

Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital

Career Start Year 2001

Number of shared co-authors 1

Chul-Kee Park

College of Medicine, Seoul National University

Career Start Year 2000

Number of shared co-authors 10

John A Boockvar

Lenox Hill Hospital

Career Start Year 1997

Number of shared co-authors 2

Vinay K Puduvalli

The University of Texas MD Anderson Cancer Center

Career Start Year 1996

Number of shared co-authors 7

Do-Hyun Nam

Samsung Medical Center, Sungkyunkwan University School

Career Start Year 1996

Number of shared co-authors 17

Tracy T Batchelor

Brigham and Women's Hospital

Career Start Year 1996

Number of shared co-authors 12

Erik P Sulman

NYU Grossman School of Medicine

Career Start Year 1995

Number of shared co-authors 13

Clark C Chen

University of Minnesota

Career Start Year 1994

Number of shared co-authors 6

David M Peereboom

Brain Tumor & Neuro-Oncology Cleveland Clinic Main Campus

Career Start Year 1993

Number of shared co-authors 6

Howard Colman

Huntsman Cancer Institute, University of Utah

Career Start Year 1990

Number of shared co-authors 14

Tom Mikkelsen

Ontario Brain Institute

Career Start Year 1990

Number of shared co-authors 17

Howard A Fine

Meyer Cancer Center

Career Start Year 1990

Number of shared co-authors 6

Morris D Groves

The University of Texas MD Anderson Cancer Center

Career Start Year 1989

Number of shared co-authors 5

Motoo Nagane

Kyorin University Faculty of Medicine

Career Start Year 1988

Number of shared co-authors 5

Marica Eoli

Fondazione IRCCS Istituto Neurologico Carlo Besta

Career Start Year 1988

Number of shared co-authors 4

Michael D Prados

University of California san francisco

Career Start Year 1987

Number of shared co-authors 10

Camilo E Fadul

University of Virginia Health System

Career Start Year 1987

Number of shared co-authors 0

Ryo Nishikawa

Saitama Medical University International Medical Center

Career Start Year 1986

Number of shared co-authors 12

Frederick F Lang

The University of Texas M.D. Anderson Cancer Center

Career Start Year 1984

Number of shared co-authors 5

Wai-Kwan Alfred Yung

University of Texas M.D. Anderson Cancer Center

Career Start Year 1974

Number of shared co-authors 15

row(s) 1 - 30 of 30

Christine Marosi

Medical University of Vienna

Co-authored papers 16

Georg Widhalm

Medical University of Vienna

Co-authored papers 12

Serge Weis

Kepler University Hospital, Johannes Kepler University

Co-authored papers 11

Matthias Preusser

Medical University of Vienna

Co-authored papers 11

Johanna Buchroithner

Johannes Kepler University

Co-authored papers 9

Johannes A Hainfellner

Medical University of Vienna

Co-authored papers 8

Karin Dieckmann

Medical University of Vienna

Co-authored papers 8

Stefan Oberndorfer

Karl Landsteiner University of Health Sciences

Co-authored papers 7

G??nther Stockhammer

Medical University of Innsbruck

Co-authored papers 6

Gord von Campe

Medical University of Graz

Co-authored papers 5

Anna S Berghoff

Co-authored papers 5

Adelheid Woehrer

Medical University of Vienna

Co-authored papers 5

Michael Weller

University Hospital and University of Zurich

Co-authored papers 4

Franz Payer

Medical University of Graz

Co-authored papers 4

Julia Furtner

Medical University of Vienna

Co-authored papers 4

Thomas Czech

Co-authored papers 3

Johannes Trenkler

Institute of Neuroradiology, Kepler University Hospital Linz

Co-authored papers 3

Claudius Thom??

Medical University Innsbruck

Co-authored papers 3

Christian F Freyschlag

Medical University of Innsbruck

Co-authored papers 3

Johannes Haybaeck

Institute of Pathology, Medical University of Innsbruck

Co-authored papers 3

Martha Nowosielski

Medical University of Innsbruck

Co-authored papers 3

Waltraud Kleindienst

Paracelsus Medical University Salzburg

Co-authored papers 2

Melitta Kitzwoegerer

Karl Landsteiner University of Health Sciences

Co-authored papers 2

Tanisa Brandner-Kokalj

Institute of Pathology, State Hospital Klagenfurt

Co-authored papers 2

Patrizia Moser

Medical University of Innsbruck

Co-authored papers 2

Felix Sahm

Hopp Children's Cancer Center Heidelberg (KiTZ)

Co-authored papers 2

Thomas Roetzer

Medical University of Vienna

Co-authored papers 2

Warren P Mason

Princess Margaret Cancer Centre

Co-authored papers 2

Benedikt Wiestler

Technical University

Co-authored papers 2

Thomas Hauser

Kepler University Hospital, Johannes Kepler University

Co-authored papers 2

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators